Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

EMA approves label update for HyQvia

Sep. 16, 2020

Q32 Bio begins phase I study with ADX-914 in healthy volunteers

Sep. 16, 2020

Praxis Biotech presents new ISR pathway inhibitors

Sep. 15, 2020

Room for improvement in T-cell repertoire profiling

Sep. 14, 2020

Sinovac reports phase I/II data on use of CoronaVac vaccine in elderly volunteers

Sep. 10, 2020

Merck Sharp & Dohme opens phase I/II study of COVID-19 vaccine candidate V-591

Sep. 10, 2020

Teaching T cells restraint

Sep. 10, 2020

Valneva advances chikungunya vaccine candidate VLA-1553 into phase III

Sep. 8, 2020

Akston signs up CRO to support phase I testing of COVID-19 vaccine candidate AKS-452

Sep. 7, 2020

Chewing the fat keeps stem cells quiet

Sep. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...